Importance Identifying brain regions associated with risk factors for dementia could guide mechanistic understanding of risk factors associated with Alzheimer disease (AD). Objectives To characterize volume changes in brain regions associated with aging and modifiable risk factors for dementia (MRFD) and to test whether volume differences in these regions are associated with cognitive performance. Design, Setting, and Participants This cross-sectional study used data from UK Biobank participants who underwent T1-weighted structural brain imaging from August 5, 2014, to October 14, 2016. A voxelwise linear model was applied to test for regional gray matter volume differences associated with aging and MRFD (ie, hypertension, diabetes, obesity...
Accumulating evidence suggests that altered cerebral white matter (WM) influences normal aging, and ...
Structural brain changes precede cognitive and clinical symptoms in Alzheimer's disease (AD). We aim...
Alzheimer’s disease (AD) has a long preclinical phase, beginning decades prior to the onset of demen...
BACKGROUND: White matter hyperintensities (WMH) of presumed vascular origin have been associated wit...
© 2014 Dr. Bob Anh TranThe experience of neurocognitive aging can be highly variable between individ...
Background: White matter hyperintensities (WMH) of presumed vascular origin have been associated wit...
The presence of cognitive impairment is a frequent complaint among elderly individuals in the genera...
We investigated in a population-based cohort study the association of global and lobar brain tissue ...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...
Introduction: Volumetric and morphological changes in subcortical brain structures are present in pe...
Background: The association between regional volumes and resting-state functional networks was teste...
Background: How the relationship between obesity and MRI-defined neural properties varies across dis...
BACKGROUND: Alzheimer's disease (AD) begins decades before the onset of dementia. There is a need to...
Structural brain changes precede cognitive and clinical symptoms in Alzheimer's disease (AD). We aim...
AIMS: Several factors are known to increase risk for cerebrovascular disease and dementia, but there...
Accumulating evidence suggests that altered cerebral white matter (WM) influences normal aging, and ...
Structural brain changes precede cognitive and clinical symptoms in Alzheimer's disease (AD). We aim...
Alzheimer’s disease (AD) has a long preclinical phase, beginning decades prior to the onset of demen...
BACKGROUND: White matter hyperintensities (WMH) of presumed vascular origin have been associated wit...
© 2014 Dr. Bob Anh TranThe experience of neurocognitive aging can be highly variable between individ...
Background: White matter hyperintensities (WMH) of presumed vascular origin have been associated wit...
The presence of cognitive impairment is a frequent complaint among elderly individuals in the genera...
We investigated in a population-based cohort study the association of global and lobar brain tissue ...
The hippocampus is one of the first regions to demonstrate atrophy during the prodromal stage of Alz...
Introduction: Volumetric and morphological changes in subcortical brain structures are present in pe...
Background: The association between regional volumes and resting-state functional networks was teste...
Background: How the relationship between obesity and MRI-defined neural properties varies across dis...
BACKGROUND: Alzheimer's disease (AD) begins decades before the onset of dementia. There is a need to...
Structural brain changes precede cognitive and clinical symptoms in Alzheimer's disease (AD). We aim...
AIMS: Several factors are known to increase risk for cerebrovascular disease and dementia, but there...
Accumulating evidence suggests that altered cerebral white matter (WM) influences normal aging, and ...
Structural brain changes precede cognitive and clinical symptoms in Alzheimer's disease (AD). We aim...
Alzheimer’s disease (AD) has a long preclinical phase, beginning decades prior to the onset of demen...